Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 1, 2010, Pages 57-61

  De, Anushtup ^a   Roy, Prabal ^a   Garg, Vinod K ^a   Pandey, Narendra K ^a  

^a FORTIS HOSPITAL   (India)

Author keywords

Deep vein thrombosis; Low molecular weight heparin; Unfractionated heparin

Indexed keywords

ENOXAPARIN; HEPARIN; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTIVE SURGERY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HEMATOMA; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; VENOUS THROMBOSIS;

EID: 75649151082     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283333505     Document Type: Article

References (17)

1. The International Multi-Center Study. The prevention of fatal postoperative pulmonary embolism by low molecular weight heparin. Lancet 1975; II:45-50.
2. Kakkar VV. The current status of low dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg 1978; 2:3-18.
3. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337:688-698.
4. Carter CJ, Kelton JG, Hirsh J, Cerskus A, Santos AV, Gent M, et al. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparins and heparin. Blood 1982; 59:1239-1245.
5. Esquivel CO, Bergqvist D, Bjork C-G, Nilsson B. Comparison between commercial heparin, low-molecular weight heparin and pentosan polysulphate on hemostasis and platelets in vivo. Thromb Res 1982; 28:389-399.
6. Feinstein DI, Rappaport SJ. Acquired inhibitors of blood coagulation. Prog Hemost Throm 1972; 1:75-95.
7. Multi Center Trial Committee. DHE/heparin prophylaxis for postoperative DVT. JAMA 1984; 251: 2960-2966.
8. The Standard Task force of the American Society of Colon and Rectal Surgeons. Practice parameters for the prevention of venous thromboembolism. Dis Colon Rectum 2000; 43:1037-1047.
9. Bergqvist D, Burmark US, Freisell J, Hallböö k T, Lindblad B, Risberg B, et al. Low molecular weight heparin once daily compared with conventional low dose heparin twice daily; a prospective double blind multicenter trial on prevention of postoperative deep vein thrombosis. Br J Surg 1986; 73:204-208.
10. Kakkar VV, Cohen AT, Edmunson RA, Phillips MJ, Cooper DJ, Das SK, et al. Low molecular weight versus standard heparin for the prevention of VTE after major abdominal surgery. Lancet 1993; 341:259-265.
11. Bergqvist D. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg 2004; 91:965-974.
12. The European Fraxiparin study (EFS) group. Comparison of Low molecular weight heparin and unfractionated heparin for the prevention of deep venous thrombosis in patients undergoing abdominal surgery. Br J Surg 1988; 75:1058-1063.
13. Gutt CN, Oniu T, Wolkener F, Mehrabi A, Mistry S, Bü chler MW. Prophylaxis and treatment of deep vein thrombosis in general surgery. Am J Surg 2005; 189:14-22.
14. McLeod RS, Geerts WH, Sniderman KW, Greenwood C, Gregoire RC, Taylor BM, et al. Subcutaneous heparin versus Low molecular weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian Colorectal DVT Prophylaxis Trial; a randomized double blind trial. Ann Surg 2001; 233:438-444.
15. Koppenhagen K, Adolf J, Matthes M, Troster E, Roder JD, et al. Low molecular weight heparin and prevention of post operative thrombosis in abdominal surgery. Thromb Haemost 1992; 67:627-630.
16. Wille Jorgenssen P, Hauch P, Dimo B, Christensen SW, Jensen R, Hansen B. Prophylaxis of deep vein thrombosis after acute abdominal operations. Surg Gynecol Obstet 1991; 172:44-48.
17. ENOXACAN Study group. Efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of deep vein thrombosis in elective cancer surgery: a double blind multicentre trial with venographic assessment. Br J Surg 1997; 84:1099-1103.